Updated:
ALS Finding a Cure
ALS Finding A Cure Foundation is a non-profit organization focused on funding research to find a cure for Lou Gehrig's disease. It operates a nationwide...
ALS Finding a Cure
ALS Finding A Cure Foundation is a non-profit organization focused on funding research to find a cure for Lou Gehrig's disease. It operates a nationwide network of chapters, providing assistance to people with ALS through multidisciplinary care and government partnerships. The organization has made 3 investments, including a Series B-II investment in Emulate on October 20, 2016, and has 1 portfolio exit, Amylyx Pharmaceuticals, on January 07, 2022.
General information
Firm type
Philanthropic Foundation
Location
Region
North America
Country
United States
City
Wellesley Hills
Corporate office
Wellesley Hills, MA, United States
Sector focus
Frequently asked questions
What is ALS Finding a Cure's primary mission?
ALS Finding a Cure funds research for amyotrophic lateral sclerosis, focusing on drug discovery, clinical trials, and patient advocacy (per the firm's tax filings, public record).
Does ALS Finding a Cure invest in for-profit biotech companies?
Public records indicate the foundation grants primarily to academic institutions and nonprofit research labs, not for-profit biotech companies.
Is ALS Finding a Cure a single family office or a charity?
It is structured as a tax-exempt philanthropic foundation, not a family office. No family is publicly listed as the funder.
What is the geographic focus of ALS Finding a Cure?
The foundation appears to concentrate on the United States, with likely ties to Boston-area research institutions (per its Massachusetts headquarters and public record).
Does ALS Finding a Cure have any publicly named principals or investment committee?
No principals or investment staff are named in public records.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: